Pyruvate Dehydrogenase Complex (Link Reaction, connecting glycolysis to the TCA cycle)
- Compartment
- Mitochondrial matrix
- Main tissue
- All aerobic tissues
- Rate-limiting
- Dihydrolipoyl transacetylase (E2); Dihydrolipoyl dehydrogenase (E3)
- Steps
- 5
Reaction steps
In source order, 5 total
-
1
Pyruvate + TPP → hydroxyethyl-TPP + CO2
› Notes
Required coenzyme: thiamine pyrophosphate (TPP), derived from vitamin B1, and Mg2+ for TPP binding. This is the first irreversible chemical event in the overall reaction; release of CO2 helps make PDC flux effectively irreversible in vivo.
-
2
Hydroxyethyl-TPP + oxidized lipoamide-E2 → acetyl-dihydrolipoamide-E2 + TPP
› Notes
Required cofactors: TPP and lipoic acid/lipoamide. The lipoamide “swinging arm” channels intermediates among active sites.
-
3
Acetyl-dihydrolipoamide-E2 + CoA-SH → acetyl-CoA + dihydrolipoamide-E2
› Notes
Required cofactor: CoA, whose reactive thiol forms the acetyl thioester. Acetyl-CoA formation is part of the overall irreversible, committed entry of pyruvate carbon into oxidative metabolism; acetyl-CoA cannot be converted back to pyruvate in humans.
-
4
Dihydrolipoamide-E2 + FAD → oxidized lipoamide-E2 + FADH2
› Notes
Required prosthetic group: tightly bound FAD; electrons are transferred from dihydrolipoamide to FAD.
-
5
FADH2 + NAD+ → FAD + NADH + H+
› Notes
Required cofactor: NAD+. The summed PDC reaction is: pyruvate + CoA-SH + NAD+ → acetyl-CoA + CO2 + NADH + H+. It is irreversible and is a major regulatory/committed step for oxidative disposal of pyruvate.
Showing all 5 steps.
Regulation
What speeds each enzyme up and what slows it down
Pyruvate dehydrogenase complex (active when dephosphorylated)
ADP, pyruvate, CoA-SH, NAD+, Ca2+ in contracting muscle; PDH phosphatase
ATP, NADH, acetyl-CoA; PDH kinase phosphorylation
Insulin activates PDH phosphatase in adipose tissue and promotes PDH activity for lipogenesis; epinephrine-associated Ca2+ signaling and muscle contraction promote phosphatase activity
Pyruvate dehydrogenase kinase (PDK)
ATP, NADH, acetyl-CoA; prolonged fasting and high fatty-acid oxidation increase PDK expression/activity
ADP, pyruvate, CoA-SH; dichloroacetate
Insulin tends to suppress PDK expression; glucagon/fasting favor PDK-mediated PDH inhibition in liver
Pyruvate dehydrogenase phosphatase (PDP)
Ca2+; Mg2+; insulin in insulin-responsive tissues
Indirectly opposed by conditions favoring PDK
Insulin stimulates PDP, particularly in adipose tissue; Ca2+ activates PDP in skeletal and cardiac muscle
Overview
The pyruvate dehydrogenase complex (PDC) catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA, thereby committing glycolytic carbon to mitochondrial oxidative metabolism. This irreversible link reaction couples pyruvate oxidation to reduction of NAD+ and conserves the remaining two-carbon acetyl group in the high-transfer-potential thioester of acetyl-CoA. PDC flux is especially important in the fed-to-fasting transition and in tissues that depend heavily on aerobic glucose oxidation, including brain, cardiac muscle, and working skeletal muscle.
Cellular location
In human cells, PDC is a large multienzyme assembly in the mitochondrial matrix; pyruvate first crosses the inner mitochondrial membrane through the mitochondrial pyruvate carrier (MPC). The matrix location places the acetyl-CoA product adjacent to the TCA cycle and the NADH product near Complex I of the respiratory chain. Brain and myocardium are highly dependent on oxidative pyruvate metabolism under usual conditions; erythrocytes lack mitochondria and therefore cannot perform this reaction.
Net energetics
For each pyruvate, PDC produces 1 acetyl-CoA, 1 NADH, and 1 CO2, with no ATP or GTP produced directly. Per glucose, two pyruvate molecules yield 2 acetyl-CoA, 2 NADH, and 2 CO2. The two matrix NADH can yield approximately 5 ATP through oxidative phosphorylation using the modern P/O estimate of about 2.5 ATP per NADH. When glycolysis, PDC, the TCA cycle, and oxidative phosphorylation are integrated, complete aerobic oxidation of one glucose yields approximately 30–32 ATP, depending chiefly on the cytosolic NADH shuttle; older textbooks often cite approximately 36–38 ATP.
Clinical significance
PDC determines whether pyruvate is oxidized to acetyl-CoA or instead diverted toward lactate, alanine, or gluconeogenic precursors. Its product acetyl-CoA also supports fatty-acid synthesis in the fed state after citrate export from mitochondria. Thiamine deficiency impairs the TPP-dependent E1 reaction and may cause impaired cerebral energy metabolism and lactic acidosis, notably in severe malnutrition or alcoholism. Inherited PDC deficiency or activating PDK states limit pyruvate oxidation, producing elevated lactate and neurologic dysfunction; dichloroacetate can activate residual PDC by inhibiting PDK in selected settings.
Recent literature
Live Europe PMC search
Europe PMC · from cache · sorted by publication date
-
1
Roxadustat attenuates contrast-induced acute kidney injury potentially mediated via the Nrf2/HO-1 signaling pathway.
Wang J, E JW, Zhang J. · 2026-05-20
open access unreviewed -
2
Explainable machine learning using urinary metabolomics to predict pediatric sepsis-associated acute kidney injury: a two-center prospective observational study.
Qian Y, Jiang Z, Miao H, Chu L, Zeng J, Fan M, Gu W, Wu M, Xu F, Ge X. · 2026-04-21
open access unreviewed -
3
Phosphatidylcholine biosynthesis via ChoC is crucial for cellular integrity and virulence in <i>Rhizopus microsporus</i>.
Carrillo-Marín P, Tahiri G, Camuña-Pardo L, Lax C, Sanchis M, Capilla J, Navarro E, Garre V, Nicolás FE. · 2026-04-16
open access unreviewed -
4
The role of copper and cuproptosis in digestive system cancers: novel therapeutic strategies and mechanistic insights.
Xu G, Yao N, Cheng R, Yang L, Han F, Qu J, Li W. · 2026-03-16
open access unreviewed -
5
A comprehensive review of the physiology and evidence base to guide the use of ergogenic and medical supplements for enhanced cycling performance.
Rowland A, Edwards S, Prieto-Bellver G, Menz B, Rowland A, Cornelisse E, Karapetis CS, Wallen MP, Hopkins AM. · 2026-02-13
open access unreviewed -
6
The molecular mechanism of cuproptosis and research progress in pancreatic diseases.
Wang Q, Chen H, Lv Z, Zhang P, Li Y, Zhao C, Li S. · 2025-12-27
cited 2× open access unreviewed -
7
Inhibition of mitochondrial complex I impedes zygotic genome activation via PDH-histone modification retrograde signaling.
Pan GX, Shi XY, Zhou LQ, Li YY. · 2026-07-14
unreviewed -
8
Low net energy diet compromises pork tenderness by promoting larger muscle fibers and diminishing intramuscular fat through fiber type reprogramming.
Wu H, Yu X, Song J, Ji F, Hu C, Peng W, Xu L, Lv R. · 2026-04-01
open access unreviewed -
9
Formate-driven efficient pyruvate biosynthesis in <i>Vibrio natriegens</i>.
Deng W, Zhang X, Liu J, Ye W, Zhu X, Jiang W, Gu Y. · 2026-03-28
open access unreviewed -
10
Physiological metabolic analysis and process optimization of hypoxia in promoting coenzyme Q<sub>10</sub> biosynthesis and accumulation in <i>Rhodobacter sphaeroides</i> HY01.
Li B, Ge Y, Fu L, Guo H, Mohsin A, Li J, Wu J, Chen B, Zhuang Y, Wang Z. · 2026-02-14
open access unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.